(FBT) First Trust NYSE Arca - Ratings and Ratios

The First Trust NYSE Arca Biotechnology Index Fund (NYSE ARCA: FBT) is an exchange-traded fund (ETF) designed to track the performance of the NYSE Arca Biotechnology Index. The fund typically allocates at least 90% of its net assets to the securities included in the index, which is an equal-dollar weighted index comprising 30 prominent biotechnology companies. This weighting approach differs from market-capitalization weighting, as it gives equal representation to each company in the index, regardless of market size. The fund is listed on the NYSE Arca exchange and falls under the Health sector category.

From a technical perspective, FBT is currently trading at $163.92, with a 20-day simple moving average (SMA) of $155.71 and a 50-day SMA of $164.50. The 200-day SMA stands at $168.58, indicating a recent dip below the longer-term trend. The Average True Range (ATR) of $4.71 suggests moderate price volatility. Fundamental analysis highlights the funds assets under management (AUM) at $989.40 million, underscoring its popularity among investors seeking exposure to the biotechnology sector.

Based on the provided data, FBTs short-term outlook appears neutral to bullish. The funds price is trading above its 20-day SMA but below its 50- and 200-day SMAs, signaling potential consolidation. The ATR of $4.71 implies that the price could fluctuate within a range of approximately $159.21 to $168.63 in the near term. Longer-term trends will depend on the performance of the underlying biotechnology companies and broader market conditions.